MedTech News
.................... by Andrew Celentano
Sweet discovery rewrites understanding of how our bodies store sugar
WEHI researchers have discovered a never-before-seen mechanism our bodies use to regulate sugar, in findings that rewrite the fundamental rules of biology and open a new frontier in science.
Whole-body ultrasound captures full cross-sections in 10 seconds, early tests show
Lihong Wang, Bren Professor of Medical Engineering and Electrical Engineering, and a team of Caltech researchers have developed a system that can perform ultrasound tomography (UST) imaging on whole cross-sections of the body.
CGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant ‘EASYMADE TI’
SEOUL, South Korea, April 24, 2026 /PRNewswire/ — CGBIO (CEO: Hyunseung Yu) announced that its patient-specific titanium implant, EASYMADE TI, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on April 9. The FDA 510(k) pathway is a premarket clearance process that demonstrates substantial equivalence to a legally marketed predicate device, allowing commercialization in the United States.
Medtronic wins CE mark for ApexCut surgical blades
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its ApexCut surgical blades for ENT procedures.
Tiny fiber probe monitors three key biomarkers at once, offering faster patient insight
A new fiber probe developed by researchers at The University of Texas at Austin delivers two major innovations in health monitoring to help both patients around the world and the clinicians who care for them.
Freeze-dried platelet product slows swelling and bleeding in traumatic brain injuries
A freeze-dried blood product that could be stored for years on ambulances or in remote emergency departments is showing promise at treating traumatic brain injuries.
How a gentler stem cell transplant may move type 1 diabetes treatment closer
A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured type 1 diabetes in mice in a study by Stanford Medicine researchers.
FDA approval of Regeneron’s hearing loss gene therapy breaks barriers
Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying cause of the condition.